PS
Phillip A Sharp (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $3.1M of ALNY (11,250 sh × $275.00, as filed), executed Jan 23 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Jan 23 2025
Filed Jan 24 2025
Median ADV $470.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ALNYRecent filings
ALNYSALE
Alnylam Pharmaceuticals, Inc.
View filing →
$3.1M11,250 sh × $275.00
Exec Jan 23 2025
Filed Jan 24 2025 · 5:30 PM ET